Virus-Based Therapy Boosts Anti-Cancer Immune Responses to Brain Cancer
February 11, 2026
February 11, 2026
BOSTON, Massachusetts, Feb. 11 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:
* * *
Virus-Based Therapy Boosts Anti-Cancer Immune Responses to Brain Cancer
*
A team led by investigators at Dana-Farber Cancer Institute and Mass General Brigham has shown that a single injection of an oncolytic virus-a genetically modified virus that selectively infects and destroys cancer cells-can recruit immune ce . . .
* * *
Virus-Based Therapy Boosts Anti-Cancer Immune Responses to Brain Cancer
*
A team led by investigators at Dana-Farber Cancer Institute and Mass General Brigham has shown that a single injection of an oncolytic virus-a genetically modified virus that selectively infects and destroys cancer cells-can recruit immune ce . . .